$5.67
-0.41 (-6.74%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-46.10%
1Y
-45.00%
YTD
-45.00%
Open$6.09
Previous Close$6.08
Day High$6.99
Day Low$5.40
52W High$13.20
52W Low$3.89
Volume—
Avg Volume81.1K
Market Cap419.54M
P/E Ratio—
EPS$-0.37
SectorN/A
Technical Indicators
Full analysis →
SMA 50
$10.47
Below
RSI (14)
64.7
Neutral
Analyst Ratings
Strong Buy
5 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 85.85M | 87.15M | 87.23M |
| Net Income | 14.62M | 13.76M | 12.83M |
| Profit Margin | 17.0% | 15.8% | 14.7% |
| EBITDA | 23.55M | 23.50M | 25.69M |
| Free Cash Flow | 13.89M | 9.49M | 13.74M |
| Rev Growth | +8.2% | +4.8% | +7.0% |
| Debt/Equity | 0.24 | 0.25 | 0.30 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $0.75 | -20.08% | — | 585.99M |
| PICS | Pics Nv | $6.89 | -7.14% | 4.1 | 961.54M |
| DMII | Drugs Made In America Acquis | $10.26 | +0.20% | 50.1 | 652.61M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.62 | +0.05% | 21.3 | 168.92M |
| CEPF | Cantor Equity Partners-Cl A | $10.35 | +0.19% | 41.5 | 590.36M |